Scholarly Index
Rebecca Dent
National Cancer Centre Singapore; 21,485 total citations; 285 total publications; best world rank #67
National Cancer Centre Singapore
21,485Total citations
285Total publications
57H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 350 | SG 2 | 98.92 |
| Advanced Breast Cancer Therapies | Lifetime | 157 | SG 1 | 98.61 |
| Cancer Treatment and Pharmacology | Lifetime | 602 | SG 2 | 98.39 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 882 | SG 2 | 98.19 |
| HER2/EGFR in Cancer Research | Lifetime | 450 | SG 1 | 98.08 |
| PARP inhibition in cancer therapy | Lifetime | 373 | SG 2 | 95.58 |
| Breast Cancer Treatment Studies | 2021-2025 | 67 | SG 1 | 99.03 |
| Advanced Breast Cancer Therapies | 2021-2025 | 74 | SG 1 | 98.77 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 411 | SG 1 | 98.39 |
| HER2/EGFR in Cancer Research | 2021-2025 | 95 | SG 1 | 98.48 |
| Cancer Treatment and Pharmacology | 2021-2025 | 99 | SG 1 | 98.07 |
| PARP inhibition in cancer therapy | 2021-2025 | 506 | SG 3 | 86.62 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 512 | SG 4 | 69.96 |